1 May 2018 - The May 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The May issue of the Schedule includes a number of new/revised listings:

• Afatinib dimaleate (Giotrif) - new medicine
  
• Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids (Neocate Syneo) - new combination product
  
• Balsalazide sodium (Colazide) - restriction change
  
• Brivaracetam (Briviact) - new medicine
  
• Pembrolizumab (Keytruda) - new indication

Read summary of changes